In 2014, 91% of Swedish men with very low risk prostate cancer opted for active surveillance.
Labeling information will include data showing the drug reduces the risk of radiographic progression versus bicalutamide.
Among patients with clear-cell renal-cell carcinoma at high risk for tumor recurrence, the duration of disease-free survival was significantly longer in the sunitinib group.
Many of the interactions between statins and other heart drugs are minor, but there are some drug combinations that should be avoided.
A low protein, low phosphorus diet plays an important role in the nutritional management of patients transitioning to once-weekly incremental hemodialysis.
The presence of a ureteral stone, age less than 30 years, and the need for intravenous narcotics in the emergency department were associated with an emergency department revisit.
Smokeless tobacco "snus" users have high blood levels of nicotine which promotes cancer progression.
A PSA level of 1.5 ng/mL or higher should prompt primary care physicians to refer patients to a urologist for further evaluation.
Young men reported improvement in executive function after 2 years of TRT.
Overweight women without diabetes who ate a high-protein diet did not show improvement in insulin sensitivity.
The prevalence of childhood and adolescent overweight and obesity leads to a substantially increased future diagnosis of diabetes.
Lack of association observed in study of hypertensive patients with normal renal function.
The risk of dementia was 2-fold higher among ADT users.
Prediagnosis obesity is a risk factor for overall and individual secondary primary cancers.
The researchers were able to isolate Zika from the semen sample in a British man recovering from the virus contracted in the Caribbean.
Renal and Urology News Articles
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)